NSAIDS-GCs Flashcards
Describe the MOA of tNSAIDS
reversible inhibition of COX1 and 2 and subsequent decrease in inflammatory prostaglandins and thromboxanes
Describe the Uses of tNSAIDs
- Pain (moderate dose)
- Fever (moderate dose)
- Inflammation (HD)
- More effective for acute pain than ASA-acetaminophen
- RA (indomethacin)
Adverse reactions of COX1 related
- GI upset/nausea
- Bleeding
- Ulceration
- Renal dysfunction/failure
- Interstitial nephritis
Adverse reactions of COX2 related
- Renal dysfunction/ failure
- Interstitial nephritis
- delayed labor/contractions
- ductus arteriosus closure
- Increase clotting risk
Adverse reactions of tNSAIDs
- similar to ASA
1. less bleeding (~2 days vs 4-7day of ASA)
2. GI upset (dyspepsia/ ulceration)
3. greater risk for renal dysfunction (reversible)
4. decrease RBF
5. fluid retention
6. increase BP (esp. in elderly)
7. OD: acute renal failure
8. Avoid in 3rd trimester pregnancy - incidence of GI toxicity reduced by concomitant use of PPIs or H2 antagonists
tNSAIDS that are mostly COX-2 inhibitors
- Meloxicam
2. Nabumetone
Analgesia and anti-inflammatory effects of NSAIDs are due to:
inhibition of inducible COX2 at site of TISSUE INJURY (PGE2/PGI2)
Anti-pyretic effects of NSAIDs are due to:
inhibition of inducible COX2 in HYPOTHALAMUS (PGE2)
Antithrombogenesis (anti-clotting) effects of NSAIDs are due to:
inhibition of constitutive COX1 in PLATELETS
4 Main groups of NSAIDs and their COX selectivity/reversibility
- tNSAIDs: reversible inhibition of COX1 and 2
- COX2 Selective inhibitors: Reversible selective inhibition of COX2
- Acetaminophen: reversible inhibition of CNS COX2
- Aspirin: irreversible inhibition of COX1 and COX2
Reversible inhibitor of COX (cyclooxygenase) 1 and 2: A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
B. Ibuprofen (Motrin®, Advil®)
C. Naproxen (Naprosyn®, Aleve®)
Which agent should be avoided in hepatic dysfunction? A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
E. Acetaminophen (Tylenol®)
*use w/ caution in pts w/ alcoholic liver dz
What NSAIDs:
- inhibits CNS COX only:
- does not have anti-inflammatory effects:
- has anti-platelet effects
- inhibits CNS COX only: acetaminophen
- does not have anti-inflammatory effects: acetaminophen
- has anti-platelet effects: aspirin
Which of the following actions of prostaglandins is INCORRECTLY matched with the form of the cyclooxygenase enzyme (COX-1 or COX-2) that synthesizes the particular prostaglandin?
A. Fever : COX-2
B. Inflammation : COX-1
C. Protection of GI cells : COX-1
D. Vasodilation in the kidney : COX-2
E. Activation of platelet aggregation : COX-1
F. Contraction of uterine smooth muscle : COX-2
G. Opening of ductus arteriosus : COX-1
B. Inflammation : COX-1
G. Opening of ductus arteriosus : COX-1
Physiological Functions of COX1
- Protection of GI cells
- Activation of platelet aggregation
- RBF maintenance
- Bone formation and resorption
Physiological Functions of COX2
- Fever
- Pain
- Inflammation (enhance edema)
- Vasodilation of the kidney
- Contraction of uterine Sm.M
- Anti-aggregatory platelet effects
- Opening of ductus arterosus
Examples of tNSAIDs
- Ibuprofen (Advil, Motrin)
- Naproxen (Aleve, Naprosyn)
- Ketoprofen
- Indomethacin
- Ketorolac (Toradol)
Describe the PK of Ibuprofen including form, absorption, administration, and elimination
- Form: PO and IV
- Absorption: rapid, complete absorption
- Administration: t1/2= 3-4hrs, BID-TID
- Elimination: Hepatic
Safest tNSAID in LD for GI tract: __
Highest risk with __
Ibuprofen (acetaminophen is safer but not a tNSAID)
Ketorolac
Describe the PK of Naproxen including form, administration, and elimination
- Form: PO
- Administration: t1/2= 12-15hrs, BID
- Elimination: RENAL
Describe the PK of Ketorolac including form and elimination
- Form: PO, IM/IV**, nasal spray
- Elimination: RENAL
Special uses of Ketorolac
- post surgical pain (IV)
* IM/IV comparable to morphine
Special uses of ibuprofen or naproxen
- Dysmenorrhea (via inhibition of synthesis of endometrial PGE)
* PG induced cramping
Adverse effects of Ketorolac
- GI toxicity –> limit use to 5 days
Relative CI of tNSAIDs
- pts w/ high risk PUD
- Advanced age
- Hx of PUD or prior NSAID gastropathy
- Concurrent GC use - 3rd trimester pregnancy
- HTN
- Diabetes
- CKD
- CHF (lowest risk w/ naproxen, highest w/ ibuprofen and celecoxib)
Safest pain medication to recommend to patients with gastric ulcers: A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
E. Acetaminophen (Tylenol®)
Safest anti-inflammatory medication to recommend to patients with gastric ulcers: A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
D. Celecoxib (Celebrex®)
If taking low-dose aspirin for cardioprotective effect – take NSAIDs for acute dental pain ___
one hour after
Safest agent for pain treatment in patients taking oral anticoagulants A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
E. Acetaminophen (Tylenol®)
What tNSAID has higher efficacy but greater toxicity
Indomethacin (PO, IV, rectal)- hepatic
MOA of Celecoxib
reversible inhibition of COX2
Describe the PK of Celecoxib including form, metabolism and elimination
Form: PO
Hepatic metabolism and renal elimination
Uses of Celecoxib
- Pain (less effective than tNSAIDs for acute pain)
- Anti-pyretic
- Inflammation (equal to tNSAIDs for osteo- and RA)
Adverse reactions of Celecoxib
- Renal dysfunction
- Delayed labor
- close ductus arteriosus
- Prothrombotic potential (NO BLEEDING RISK)
5 increase MI risk and HF - Lower risk of GI toxicity*
- hypersensitivity rxn due to sulfa moiety
**Black box warning: increased CV thrombotic events
___ is an option for patients requiring chronic NSAID treatment at high risk for gastric complications (high RF include: ___)
Celicoxib
- Age >65
- use of an anticoagulant
- prior GI bleed
- active PUD
- concurrent use of oral GCs
Side Effects - Platelets No alteration of platelet function or increase in bleeding risk
-No inhibition of COX-1 mediated TXA 2 synthesis in platelets
Celecoxib
BLACK BOX WARNING
- Increased risk of adverse cardiovascular thrombotic events
- Possibly due to selective inhibition of anti-aggregatory PGI 2 in endothelial cells
Celecoxib
A 64-year-old male presents with mild to moderate musculoskeletal back pain after playing golf. He states he has tried acetaminophen and that it did not help. His past medical history includes diabetes, HTN, hyperlipidemia, gastric ulcer (resolved), coronary artery disease. Which of the following is the most appropriate NSAID regimen to treat this patient’s pain? A. Celecoxib B. Ketorolac and omeprazole C. Naproxen and omeprazole D. Naproxen E. Ibuprofen
C. Naproxen and omeprazole
for naproxen, ibuprofen and celicoxib, compare the GI risk, CVS risk and renal risk
GI: naproxen> ibuprofen> celicoxib (COX1>COX2 inhibition)
CVS: celecoxib > ibuprofen = naproxen (COX2>COX1)
Renal: celecoxib = ibuprofen = naproxen (COX2=COX2)
The primary reason for developing drugs that selectively inhibit the COX-2 enzyme (e.g., celecoxib [Celebrex®]) is to:
A. Decrease the risk of myocardial infarction
B. Improve anti-inflammatory effectiveness
C. Lower the risk of gastrointestinal toxicity associated with existing anti-inflammatory agents
D. Reduce the cost of treatment of rheumatoid arthritis
E. Selectively decrease levels of thromboxane A2
C. Lower the risk of gastrointestinal toxicity associated with existing anti-inflammatory agents
Safest agent to treat musculoskeletal pain in patients with kidney dysfunction: A. Aspirin B. Ibuprofen (Motrin®, Advil®) C. Naproxen (Naprosyn®, Aleve®) D. Celecoxib (Celebrex®) E. Acetaminophen (Tylenol®)
E. Acetaminophen (Tylenol®)